Valerie Jansen
Fortuna: - $ al 31/08/2026
Fortuna: - $ al 31/08/2026
Valerie Malyvanh Jansen is currently an Independent Director at OnKure Therapeutics, Inc. since 2024.
Former roles include Chief Medical Officer at Elevation Oncology, Inc. from 2021 to 2025 and Executive Medical Director at Mersana Therapeutics, Inc. from 2020 to 2021.
Education includes undergraduate studies at Maryville College, and doctorate degrees from The University of Tennessee Health Science Center and Pritzker School of Medicine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
-.--% | 07/08/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
| Empresas | Cargo | Inicio |
|---|
| Empresas | Cargo | Fin |
|---|---|---|
| ELEN ONCO | Director Técnico/Científico/I+D | 31/03/2025 |
| MERSANA THERAPEUTICS | Director Técnico/Científico/I+D | 01/04/2021 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Mersana Therapeutics, Inc.
Mersana Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures antibody drug conjugates to improve patient outcomes in multiple oncology indications | Health Technology |
Maryville College
Maryville College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The University of Tennessee Health Science Center
The University of Tennessee Health Science Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pritzker School of Medicine
Pritzker School of Medicine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Elevation Oncology, Inc.
Elevation Oncology, Inc. BiotechnologyHealth Technology Develops elevating precision medicines for cancer treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.